Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial)

Lambert, Martin; Bock, Thomas; Schöttle, Daniel; Golks, Dietmar; Meister, Klara; Rietschel, Liz; Bussopulos, Alexandra; Frieling, Marietta; Schödlbauer, Michael; Burlon, Marc; Huber, Christian G; Ohm, Gunda; Pakrasi, Manoshi; Chirazi-Stark, Michael Sadre; Naber, Dieter; Schimmelmann, Benno G (2010). Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial). Journal of clinical psychiatry, 71(10), pp. 1313-23. Memphis, Tenn.: Physicians Postgraduate Press 10.4088/JCP.09m05113yel

Full text not available from this repository. (Request a copy)

The ACCESS trial examined the 12-month effectiveness of continuous therapeutic assertive community treatment (ACT) as part of integrated care compared to standard care in a catchment area comparison design in patients with schizophrenia spectrum disorders treated with quetiapine immediate release.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy

UniBE Contributor:

Schimmelmann, Benno Karl Edgar

ISSN:

0160-6689

Publisher:

Physicians Postgraduate Press

Language:

English

Submitter:

Myriam Pyrlik

Date Deposited:

04 Oct 2013 14:11

Last Modified:

05 Dec 2022 14:01

Publisher DOI:

10.4088/JCP.09m05113yel

PubMed ID:

20361911

Web of Science ID:

000285444100007

URI:

https://boris.unibe.ch/id/eprint/1709 (FactScience: 203639)

Actions (login required)

Edit item Edit item
Provide Feedback